Sasaki K, Takahashi M, Hashimoto T, Kawachnino K
Department of Pathology, Yamaguchi University School of Medicine, Ube, Japan.
Pathol Res Pract. 1989 Jun;184(6):561-6. doi: 10.1016/S0344-0338(89)80160-8.
The relationship of DNA ploidy to clinical, pathological or prognostic data was investigated in 70 surgically removed gastric cancers, 60 of which were advanced cases. The cellular DNA content was measured by means of flow cytometry. Overall, DNA aneuploidy was seen in 43 of the cases (61%) while the normal gastric mucosa consisted of only a diploid line without any aneuploid population. Ploidy levels of gastric cancer spanned a wide range from a hypodiploid value to a hyperpentaploid value, although near-diploid and near-triploid cases were the majority in the series. No significant association between ploidy and either age or sex was found. The incidence of DNA aneuploidy was significantly higher in differentiated adenocarcinomas than in undifferentiated ones (p less than 0.05). However, DNA ploidy was not related to some pathologic characteristics such as the extent of tumor invasion and the frequency of lymph node metastasis. According to Kaplan-Meier survival plots, prognosis of the patients with DNA diploid tumors tended to be better than that of aneuploid tumors, but the difference was not statistically significant.
在70例手术切除的胃癌中研究了DNA倍体与临床、病理或预后数据之间的关系,其中60例为进展期病例。通过流式细胞术测量细胞DNA含量。总体而言,43例(61%)病例出现DNA非整倍体,而正常胃黏膜仅由二倍体细胞系组成,无任何非整倍体细胞群。胃癌的倍体水平范围很广,从亚二倍体值到超五倍体值,尽管该系列中近二倍体和近三倍体病例占多数。未发现倍体与年龄或性别之间存在显著关联。分化型腺癌中DNA非整倍体的发生率显著高于未分化型腺癌(p<0.05)。然而,DNA倍体与肿瘤浸润范围和淋巴结转移频率等一些病理特征无关。根据Kaplan-Meier生存曲线,DNA二倍体肿瘤患者的预后往往优于非整倍体肿瘤患者,但差异无统计学意义。